Literature DB >> 7547432

Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.

R J van't Hof1, A C Tuinenburg-Bol Raap, P J Nijweide.   

Abstract

It has been established, that the osteoclast is derived from the haemopoietic stem cell, but its exact lineage is still controversial. It is sometimes suggested, that osteoclasts and monocytes/macrophages are related cells. It has also been suggested that osteoclast differentiation is regulated by osteoblasts and 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). In the present paper we addressed the question whether avian monocytes can differentiate into osteoclasts in vitro, using an array of immunocytochemical, enzyme cytochemical and function markers. We have also determined the effects of osteoblasts, osteoblast conditioned medium and 1,25-(OH)2D3 on the expression of osteoclastic features on monocytes during culture. Monocytes developed tartrate resistant acid phosphatase (TRAcP) enzyme activity and antigens for all anti-osteoclast antibodies tested, during culture. However, they did not acquire the ability to resorb dentine and still showed phagocytosis of latex spheres. This indicates that the monocytes developed into cells resembling osteoclasts but lacking their function while retaining the function of macrophages. Osteoblast conditioned medium stimulated TRAcP enzyme activity and proliferation of monocytes in cultures. Addition of osteoblasts or osteoblast conditioned medium to monocyte cultures on dentine in the presence or absence of 1,25-(OH)2D3 did not result in the generation of genuine osteoclasts, nor in pit formation. 1,25-(OH)2D3 appeared to be cytotoxic to the avian monocytes in concentrations considered optimal for mouse osteoclast formation. These results suggest that avian monocytes do not readily differentiate into osteoclasts under in vitro conditions that stimulate osteoclast differentiation from bone marrow derived haemopoietic cells. Furthermore, labelling with anti-osteoclast antibodies and TRAcP as osteoclast-markers should be used only with great caution in the identification of osteoclasts formed in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547432      PMCID: PMC1997173     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  38 in total

1.  Evidence for stem cells in the peripheral blood of mice.

Authors:  J W GOODMAN; G S HODGSON
Journal:  Blood       Date:  1962-06       Impact factor: 22.113

2.  Osteoclasts and a small population of peripheral blood cells share common surface antigens.

Authors:  T A Hentunen; J Tuukkanen; H K Väänänen
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

3.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Osteoclast formation from cloned pluripotent hemopoietic stem cells.

Authors:  C E Hagenaars; A A van der Kraan; E W Kawilarang-de Haas; J W Visser; P J Nijweide
Journal:  Bone Miner       Date:  1989-05

5.  Immunocytochemical analysis of the human osteoclast: phenotypic relationship to other marrow-derived cells.

Authors:  N A Athanasou; J Quinn; J O McGee
Journal:  Bone Miner       Date:  1988-03

6.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  The effects of parathyroid hormone or 1,25-dihydroxyvitamin D3 on monocyte-osteoclast fusion.

Authors:  A Teti; G Volleth; A Carano; A Zambonin Zallone
Journal:  Calcif Tissue Int       Date:  1988-05       Impact factor: 4.333

8.  Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.

Authors:  G Hattersley; T J Chambers
Journal:  Endocrinology       Date:  1989-04       Impact factor: 4.736

9.  A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro.

Authors:  G B Schneider; M Relfson
Journal:  Bone       Date:  1988       Impact factor: 4.398

10.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.

Authors:  J Davies; J Warwick; N Totty; R Philp; M Helfrich; M Horton
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

View more
  3 in total

1.  Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.

Authors:  Ning Wang; Bernard Robaye; Ankita Agrawal; Timothy M Skerry; Jean-Marie Boeynaems; Alison Gartland
Journal:  Mol Endocrinol       Date:  2011-11-22

2.  The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro.

Authors:  Ankita Agrawal; Katherine A Buckley; Keith Bowers; Mark Furber; James A Gallagher; Alison Gartland
Journal:  Purinergic Signal       Date:  2010-04-21       Impact factor: 3.765

3.  Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans.

Authors:  Liesbeth Van Wesenbeeck; Paul R Odgren; Fraser P Coxon; Annalisa Frattini; Pierre Moens; Bram Perdu; Carole A MacKay; Els Van Hul; Jean-Pierre Timmermans; Filip Vanhoenacker; Ruben Jacobs; Barbara Peruzzi; Anna Teti; Miep H Helfrich; Michael J Rogers; Anna Villa; Wim Van Hul
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.